In this episode Oriel chats to Jennifer Chow, CEO & managing director ofChimeric Therapeutics (ASX:CHM)and Dr Deborah Rathjen, CEO ofCarina Biotech.
Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer.
Carina Biotech is an Australian pre-clinical immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers.
The panel discuss a range of topics including where we are on the road to finding a cure to cancer, CAR-T treatments, R&D capital and who is paying for it, collaborations in the CAR-T field, what investors can expect from these companies in the next 12 months.
(20min delay)